---
figid: PMC4807882__bcbcr-10-2016-025f3
figtitle: A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer
organisms:
- NA
pmcid: PMC4807882
filename: bcbcr-10-2016-025f3.jpg
figlink: /pmc/articles/PMC4807882/figure/f3-bcbcr-10-2016-025/
number: F3
caption: 'Schematic overview of the therapeutic targets that are currently being tested
  in clinical trials among patients with mTNBC.Abbreviations: PI3K, phosphatidylinositol
  3-kinase; MEK, mitogen-activated protein kinase kinase; Akt, v-Akt murine thymoma
  viral oncogene; mTOR, mammalian target of rapamycin; HSP-90, heat shock protein
  90; CXCR, chemokine receptor; HDAC, histone deacetylase; PARP, poly adenosine diphosphate-ribose
  polymerase; Trop-2, tumor-associated calcium signal transducer 2; GPNMB, glycoprotein
  nonmetastatic b; EGFR, epidermal growth factor receptor; VEGFR, vascular endothelial
  growth; PD1, programmed death 1; PDL1, programmed death ligand 1; CTLA4, cytotoxic
  T-lymphocyte-associated protein 4; AR, androgen receptor; CYP17A1, cytochrome P450
  17A1; CSF1R, colony-stimulating factor 1 receptor; JAK1/2, janus kinase 1 and 2;
  Sine XPO1, selective inhibitor of nuclear export exportin 1; VDR, vitamin D pathway
  receptor genes; HMGCR, HMG-CoA reductase; RAS, rat sarcoma; RAF, B-raf and v-Raf
  murine sarcoma viral oncogene homolog B; ERK, extracellular signal-regulated kinases;
  STAT, signal transducer and activator of transcription; GRB2, growth factor receptor-bound
  protein 2; TNBC, triple-negative breast cancer.'
papertitle: A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer.
reftext: Simon B. Zeichner, et al. Breast Cancer (Auckl). 2016;10:25-36.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8993799
figid_alias: PMC4807882__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4807882__F3
ndex: 53ac4142-df10-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4807882__bcbcr-10-2016-025f3.html
  '@type': Dataset
  description: 'Schematic overview of the therapeutic targets that are currently being
    tested in clinical trials among patients with mTNBC.Abbreviations: PI3K, phosphatidylinositol
    3-kinase; MEK, mitogen-activated protein kinase kinase; Akt, v-Akt murine thymoma
    viral oncogene; mTOR, mammalian target of rapamycin; HSP-90, heat shock protein
    90; CXCR, chemokine receptor; HDAC, histone deacetylase; PARP, poly adenosine
    diphosphate-ribose polymerase; Trop-2, tumor-associated calcium signal transducer
    2; GPNMB, glycoprotein nonmetastatic b; EGFR, epidermal growth factor receptor;
    VEGFR, vascular endothelial growth; PD1, programmed death 1; PDL1, programmed
    death ligand 1; CTLA4, cytotoxic T-lymphocyte-associated protein 4; AR, androgen
    receptor; CYP17A1, cytochrome P450 17A1; CSF1R, colony-stimulating factor 1 receptor;
    JAK1/2, janus kinase 1 and 2; Sine XPO1, selective inhibitor of nuclear export
    exportin 1; VDR, vitamin D pathway receptor genes; HMGCR, HMG-CoA reductase; RAS,
    rat sarcoma; RAF, B-raf and v-Raf murine sarcoma viral oncogene homolog B; ERK,
    extracellular signal-regulated kinases; STAT, signal transducer and activator
    of transcription; GRB2, growth factor receptor-bound protein 2; TNBC, triple-negative
    breast cancer.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - CXCR1
  - EGF
  - CSF2
  - LAMC2
  - CTLA4
  - PDCD1
  - RPL17
  - SNCA
  - SPATA2
  - RPL17-C18orf32
  - GRB2
  - SRC
  - FGR
  - FYN
  - YES1
  - KRAS
  - HRAS
  - NRAS
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - PI3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - CYP17A1
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - AR
  - VDR
  - CYP27B1
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
